These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12905643)

  • 21. [PPAR family (PPAR alpha, PPAR delta, PPAR gamma)].
    Kamon J; Yamauchi T; Kadowaki T
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():593-600. PubMed ID: 12238104
    [No Abstract]   [Full Text] [Related]  

  • 22. Regulation of the peroxisomal beta-oxidation-dependent pathway by peroxisome proliferator-activated receptor alpha and kinases.
    Latruffe N; Cherkaoui Malki M; Nicolas-Frances V; Clemencet MC; Jannin B; Berlot JP
    Biochem Pharmacol; 2000 Oct; 60(8):1027-32. PubMed ID: 11007938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and function of peroxisome proliferator-activated receptors in human melanocytes.
    Kang HY; Chung E; Lee M; Cho Y; Kang WH
    Br J Dermatol; 2004 Mar; 150(3):462-8. PubMed ID: 15030328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Narrowing in on cardiovascular disease: the atheroprotective role of peroxisome proliferator-activated receptor gamma.
    Gerry JM; Pascual G
    Trends Cardiovasc Med; 2008 Feb; 18(2):39-44. PubMed ID: 18308193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP) but not PPAR-interacting protein (PRIP) is required for nuclear translocation of constitutive androstane receptor in mouse liver.
    Guo D; Sarkar J; Ahmed MR; Viswakarma N; Jia Y; Yu S; Sambasiva Rao M; Reddy JK
    Biochem Biophys Res Commun; 2006 Aug; 347(2):485-95. PubMed ID: 16828057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary regulation of nuclear receptors in obesity-related metabolic syndrome.
    Kawada T; Goto T; Hirai S; Kang MS; Uemura T; Yu R; Takahashi N
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():126-30. PubMed ID: 18296319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.
    Duan SZ; Usher MG; Mortensen RM
    Circ Res; 2008 Feb; 102(3):283-94. PubMed ID: 18276926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
    Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
    Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression.
    Schoonjans K; Staels B; Auwerx J
    J Lipid Res; 1996 May; 37(5):907-25. PubMed ID: 8725145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of PPAR transactivation switches cell fate of bone marrow stem cells from adipocytes into osteoblasts.
    Takada I; Suzawa M; Matsumoto K; Kato S
    Ann N Y Acad Sci; 2007 Nov; 1116():182-95. PubMed ID: 17656564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PPARs and the complex journey to obesity.
    Evans RM; Barish GD; Wang YX
    Nat Med; 2004 Apr; 10(4):355-61. PubMed ID: 15057233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators.
    Theocharis S; Margeli A; Vielh P; Kouraklis G
    Cancer Treat Rev; 2004 Oct; 30(6):545-54. PubMed ID: 15325034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
    Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
    Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implications of peroxisome proliferator-activated receptors (PPARS) in development, cell life status and disease.
    Keller JM; Collet P; Bianchi A; Huin C; Bouillaud-Kremarik P; Becuwe P; Schohn H; Domenjoud L; Dauça M
    Int J Dev Biol; 2000 Aug; 44(5):429-42. PubMed ID: 11032176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisome proliferator-activated receptors as molecular targets for drug therapy.
    Sridhar GR
    J Assoc Physicians India; 2003 Jan; 51():49-52. PubMed ID: 12693455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [PPAR gamma: a major nuclear receptor in adipogenesis].
    Gervois P; Fruchart JC
    Med Sci (Paris); 2003 Jan; 19(1):20-2. PubMed ID: 12836187
    [No Abstract]   [Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptors, orphans with ligands and functions.
    Schoonjans K; Martin G; Staels B; Auwerx J
    Curr Opin Lipidol; 1997 Jun; 8(3):159-66. PubMed ID: 9211064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear receptors. I. PPAR gamma in the gastrointestinal tract: gain or pain?
    Auwerx J
    Am J Physiol Gastrointest Liver Physiol; 2002 Apr; 282(4):G581-5. PubMed ID: 11897616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators.
    Corton JC; Anderson SP; Stauber A
    Annu Rev Pharmacol Toxicol; 2000; 40():491-518. PubMed ID: 10836145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome proliferator-activated receptors (PPARS) and carcinogenesis.
    Vanden Heuvel JP
    Toxicol Sci; 1999 Jan; 47(1):1-8. PubMed ID: 10048147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.